Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
about
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer TherapyTargeting BCL2-Proteins for the Treatment of Solid TumoursRestoration of mitochondria function as a target for cancer therapyAntitumor Activity of 2,9-Di-Sec-Butyl-1,10-PhenanthrolineBM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivoBcl-xL overexpression and its association with the progress of tongue carcinoma.Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxelIdentification of mRNA isoform switching in breast cancer.Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.Oncogenic miR-9 is a target of erlotinib in NSCLCsTargeting KRAS-mutant non-small cell lung cancer: challenges and opportunities.Killing Two Cells with One Stone: Pharmacologic BCL-2 Family Targeting for Cancer Cell Death and Immune Modulation.ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics.The influential role of BCL2 family members in synovial sarcomagenesis.MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.Modulation of Bax and mTOR for Cancer Therapeutics.Conversion of MIG6 peptide from the nonbinder to binder of lung cancer-related EGFR by phosphorylation and cyclization.Pathways and mechanisms of venetoclax resistance.Bcl-2 family in non-small cell lung cancer: its prognostic and therapeutic implications.MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis.A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.Antigen-specific primed cytotoxic T cells eliminate tumour cells in vivo and prevent tumour development, regardless of the presence of anti-apoptotic mutations conferring drug resistance.Role of Mitochondria-Associated ER Membranes in Calcium Regulation in Cancer-Specific Settings.Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development
P2860
Q24337757-AF00836A-31C3-46D6-8F62-65C9BD7C82B0Q26853686-C2F89553-15CC-4DB2-B9FC-88C9ADFFD6CEQ26864167-C9060730-1AE1-4B57-B3E4-E44BBE588A41Q28468510-E3E87B70-3586-4AB0-9288-AE498A5F54BCQ28539452-28C754E1-9989-43D5-B664-055D3B6C52F4Q34732893-521F9657-54F5-4C45-88B0-A3BBC86EC7F8Q35742549-689AEE16-376C-4071-A85E-39F1AE0E817EQ35945158-BA52A81F-7D1B-423D-AE5D-BE0BFA33F17EQ35966191-5A7A0921-04C9-4C63-8222-43E76FDE307FQ36140699-08359DBE-F72C-4012-83BD-A2164435FDAFQ36305862-9687BB0E-36D3-48A2-A6FA-538140429ED2Q36398758-247D15FC-3A8E-42C6-AB51-BF36DD6ABAB2Q37521403-FB639DB6-B2BE-47EF-873F-6BCA9069EB4CQ37712188-3953A036-B415-45F9-A128-0E1BDD17B00EQ38930539-1BA2D684-6B62-493A-AF1A-10305722AB92Q40066050-57AC19A3-3C79-40A4-B8D4-59351B26BB8CQ41520375-A70EF92D-B4E0-414A-9CE0-A6035DD9F48BQ47405155-3D1F85D4-775E-4670-B092-8663F4C68A97Q50662513-014D8E6D-690A-4EFA-BB31-4C20D0C2F159Q50792383-87BB2108-DC25-4A4A-AE55-A515E4263400Q51160342-088FB060-B396-4887-8201-AEA4AB07FEF7Q51181824-3469D0A7-7B84-4DFB-B1A8-0B0FAB9AEC58Q52659036-B438FDCE-3FDB-4576-8BCF-2D750E2A78FFQ52689258-CC6776C3-C8C7-40B8-895D-3751FB7BCB92Q53685196-E50F2100-534C-4723-A409-8BD8EE70705AQ53827160-86B79A2C-CD86-4888-AF76-F67D97068BF8Q57107532-4AE47C69-E42B-4568-833F-89D465680860
P2860
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@ast
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@en
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@nl
type
label
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@ast
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@en
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@nl
prefLabel
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@ast
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@en
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
@nl
P2093
P2860
P1433
P1476
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer
@en
P2093
Dongkyoo Park
Fadlo R Khuri
Gabriel L Sica
Shi-Yong Sun
Suresh S Ramalingam
Taofeek K Owonikoko
Walter J Curran
Xingming Deng
P2860
P304
P356
10.1158/0008-5472.CAN-12-2272
P407
P577
2013-07-03T00:00:00Z